Related Experiment Video
Updated: Oct 11, 2026

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
Published on: February 21, 2011
Restrictions on smoking at home and urinary cotinine levels among children with asthma
M Wakefield1, D Banham, J Martin
1Health Research and Policy Centers, University of Illinois at Chicago, Illinois 60607, USA. melaniew@uic.edu
Insights
Implementing a total ban on home smoking significantly reduces children's exposure to environmental tobacco smoke (ETS). Even partial restrictions are better than no rules, but exceptions diminish protection against ETS.
Area of Science:
- Environmental Health
- Pediatric Pulmonology
- Public Health Policy
Background:
- Children with asthma are particularly vulnerable to environmental tobacco smoke (ETS).
- Home smoking restrictions are a common strategy to reduce children's ETS exposure.
- The effectiveness of varying levels of home smoking bans requires further investigation.
Purpose of the Study:
- To assess the association between different home smoking restriction levels and children's ETS exposure.
- To quantify children's exposure to ETS using urinary cotinine-to-creatinine ratios (CCR).
Main Methods:
- Cross-sectional survey of 249 children (aged 1-11) with asthma and at least one smoking parent.
- Measurement of urinary cotinine-to-creatinine ratios (CCR) as a biomarker for ETS exposure.
- Statistical adjustment for child's age, mother's smoking status, and parental daily cigarette consumption.
Main Results:
- A total smoking ban at home was associated with the lowest urinary CCR levels (7.6 nmol/mmol).
- Partial bans with exceptions (14.9 nmol/mmol) or smoking limited to specific rooms (14.1 nmol/mmol) showed similar, higher CCR levels.
- Unrestricted smoking in the home resulted in the highest CCR levels (26.0 nmol/mmol).
Conclusions:
- Exceptions to home smoking bans significantly reduce their protective impact.
- Even partial restrictions, like limiting smoking to certain rooms, can lower children's ETS exposure compared to unrestricted smoking.
Objectives:
The purpose of this study was to determine the extent to which various levels of restrictions on smoking in the home may be associated with children's exposure to environmental tobacco smoke (ETS).
Methods:
The methodology consisted of a cross-sectional survey involving 249 children with asthma aged 1 to 11 attending hospital outpatient clinics, with at least one parent who smoked, linked to the child's urinary cotinine to creatinine ratios (CCR).
Results:
After adjustment for child's age, mother's smoking status, and total parental daily cigarette consumption, a total ban was associated with significantly lower urinary CCR levels (7.6 nmol/mmol) than bans with exceptions or limited smoking in the home. Where exceptions to bans were made (14.9 nmol/mmol), children's urinary CCR levels were no different from homes in which smoking was allowed in rooms the child rarely frequented (14.1 nmol/mmol). These two intermediate levels of restriction were in turn associated with significantly lower CCR levels than unrestricted smoking in the home (26.0 nmol/mmol).
Conclusions:
Making exceptions to bans on smoking at home measurably undermines the protective effect of a ban. However, making some exceptions to a ban and limiting smoking to rooms where the child rarely goes may result in reduced exposure to ETS, compared with unrestricted smoking.
More Related Videos
Related Concept Videos
Asthma-I: Introduction
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Asthma I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma III: Clinical Manifestations

